RPC's 3rd Medical Conference Participation This Year TUSTIN, CA, May 18, 2011 (MARKETWIRE via COMTEX) -- Radient Pharmaceuticals Corporation "RPC" /quotes/comstock/14*!rpc/quotes/nls/rpc RPC +3.75% , a developer and global marketer of In Vitro...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Radient Pharmaceuticals to Exhibit Onko-Sure(R) Cancer Test at the American Society of Clinial Oncology (ASCO) Annual Meeting
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account